Syntiron Revenue and Competitors
Estimated Revenue & Valuation
- Syntiron's estimated annual revenue is currently $1.9M per year.
- Syntiron's estimated revenue per employee is $155,000
Employee Data
- Syntiron has 12 Employees.
- Syntiron grew their employee count by 33% last year.
Syntiron's People
| Name | Title | Email/Phone |
|---|
Syntiron Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.3M | 60 | 20% | N/A | N/A |
#2 | $9.1M | 59 | -34% | N/A | N/A |
#3 | $1.1M | 7 | 17% | N/A | N/A |
#4 | $0.3M | 2 | -93% | N/A | N/A |
#5 | $4.3M | 28 | 4% | N/A | N/A |
#6 | $1.4M | 9 | 50% | N/A | N/A |
#7 | $6M | 39 | 3% | N/A | N/A |
#8 | $15.8M | 102 | 7% | N/A | N/A |
#9 | $18M | 116 | 0% | $20.5M | N/A |
#10 | $34.1M | 176 | 13% | $39.1M | N/A |
What Is Syntiron?
Syntiron LLC, is dedicated to developing innovative vaccines for humans. Our patented microbial antigen discovery and purification technology targets proteins that acquire iron, a critical nutrient that is required for survival of the bacteria. These proteins are expressed on the cell surface and are similar among different strains, making them ideal vaccine antigens. Our proprietary platform enables rapid identification of these proteins, which can then be directly extracted from the host cell or produced recombinantly for preclinical vaccine development.
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Saint Paul
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | -20% | N/A |
#2 | $2.1M | 14 | 0% | N/A |
#3 | $1.5M | 15 | N/A | N/A |
#4 | $1.4M | 16 | -6% | N/A |
#5 | $2.1M | 17 | -39% | N/A |